114 related articles for article (PubMed ID: 11204054)
41. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
42. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
43. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
[TBL] [Abstract][Full Text] [Related]
44. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
Shin MS; Helmstetter FJ
Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
[TBL] [Abstract][Full Text] [Related]
45. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
46. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
47. Hypoxia modulates cholinergic but not opioid activation of G proteins in rat hippocampus.
Hambrecht VS; Vlisides PE; Row BW; Gozal D; Baghdoyan HA; Lydic R
Hippocampus; 2007; 17(10):934-42. PubMed ID: 17598161
[TBL] [Abstract][Full Text] [Related]
48. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
49. Colocalization of mu-opioid receptors and activated G-proteins in rat cingulate cortex.
Vogt LJ; Sim-Selley LJ; Childers SR; Wiley RG; Vogt BA
J Pharmacol Exp Ther; 2001 Dec; 299(3):840-8. PubMed ID: 11714867
[TBL] [Abstract][Full Text] [Related]
50. Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat.
Gauthier EA; Guzick SE; Brummett CM; Baghdoyan HA; Lydic R
Anesthesiology; 2011 Oct; 115(4):743-53. PubMed ID: 21857500
[TBL] [Abstract][Full Text] [Related]
51. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
52. Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate.
Daunais JB; Letchworth SR; Sim-Selley LJ; Smith HR; Childers SR; Porrino LJ
J Comp Neurol; 2001 May; 433(4):471-85. PubMed ID: 11304712
[TBL] [Abstract][Full Text] [Related]
53. Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function.
Tershner SA; Mitchell JM; Fields HL
Pain; 2000 Mar; 85(1-2):153-9. PubMed ID: 10692614
[TBL] [Abstract][Full Text] [Related]
54. μ-Opioid modulation in the rostral solitary nucleus and reticular formation alters taste reactivity: evidence for a suppressive effect on consummatory behavior.
Kinzeler NR; Travers SP
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R690-700. PubMed ID: 21697523
[TBL] [Abstract][Full Text] [Related]
55. Activating mu-opioid receptors in the lateral parabrachial nucleus increases c-Fos expression in forebrain areas associated with caloric regulation, reward and cognition.
Denbleyker M; Nicklous DM; Wagner PJ; Ward HG; Simansky KJ
Neuroscience; 2009 Aug; 162(2):224-33. PubMed ID: 19422884
[TBL] [Abstract][Full Text] [Related]
56. The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.
Tao PL; Lee CR; Law PY; Loh HH
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):504-8. PubMed ID: 8114950
[TBL] [Abstract][Full Text] [Related]
57. Activation of opioid micro-receptors in medullary raphe depresses sighs.
Zhang Z; Xu F; Zhang C; Liang X
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1528-37. PubMed ID: 19244586
[TBL] [Abstract][Full Text] [Related]
58. Microinjection of an adenosine A1 agonist into the medial pontine reticular formation increases tail flick latency to thermal stimulation.
Tanase D; Baghdoyan HA; Lydic R
Anesthesiology; 2002 Dec; 97(6):1597-601. PubMed ID: 12459690
[TBL] [Abstract][Full Text] [Related]
59. Adenosine A(1) receptors in mouse pontine reticular formation depress breathing, increase anesthesia recovery time, and decrease acetylcholine release.
Gettys GC; Liu F; Kimlin E; Baghdoyan HA; Lydic R
Anesthesiology; 2013 Feb; 118(2):327-36. PubMed ID: 23263018
[TBL] [Abstract][Full Text] [Related]
60. Hypocretin-1 causes G protein activation and increases ACh release in rat pons.
Bernard R; Lydic R; Baghdoyan HA
Eur J Neurosci; 2003 Oct; 18(7):1775-85. PubMed ID: 14622212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
